Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APIDRA vs APREPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APIDRA vs APREPITANT: Safety Overview

Metric APIDRA APREPITANT
Total FAERS Reports 183 5,620
Deaths Reported 21 1,195
Death Rate 11.5% 21.3%
Hospitalizations 58 2,917
Average Patient Age 57.6 yrs 52.8 yrs
% Female Patients N/A 70.9%
FDA Approval Date N/A Dec 17, 2015
Manufacturer N/A Heron Therapeutics, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription